About eltrombop ag olamine
Thrombopoietin receptor agonist
Used for
- Raises platelet counts in chronic immune thrombocytopenia.
- Treats low platelets in hepatitis C patients receiving antiviral therapy.
- Treats severe aplastic anemia in selected patients.
Usual adult dose
Usually starts at 50 mg once daily for immune thrombocytopenia or hepatitis C; dose depends on response and liver function. Aplastic anemia dosing varies.
Usual dose in children
For immune thrombocytopenia, usually starts at 25 mg once daily for ages 1–5, or 50 mg for ages 6 and older; specialist-directed adjustments.
Common side effects
- Nausea, diarrhea, or headache
- Elevated liver enzymes
- Blood clots
- Cataracts
Important warnings
- Requires regular blood counts and liver tests.
- Food, dairy, antacids, and mineral supplements can reduce absorption; separate dosing.
- Stopping treatment may cause platelet counts to fall again.
- Excessive platelet increases can raise clot risk.
Pregnancy
Use only when clearly needed; human pregnancy information is limited.
Breastfeeding
Unknown whether it passes into breast milk; discuss risks with a clinician.
Interactions
- Calcium-rich foods, antacids, iron, and other minerals reduce absorption.
- May interact with medicines affected by OATP1B1 or BCRP transporters.
- May interact with some cholesterol-lowering medicines, including rosuvastatin.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.